Suppr超能文献

相似文献

1
LncRNA UCA1 attenuated the killing effect of cytotoxic CD8 + T cells on anaplastic thyroid carcinoma via miR-148a/PD-L1 pathway.
Cancer Immunol Immunother. 2021 Aug;70(8):2235-2245. doi: 10.1007/s00262-020-02753-y. Epub 2021 Jan 24.
2
LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.
Life Sci. 2019 Aug 15;231:116335. doi: 10.1016/j.lfs.2019.03.040. Epub 2019 Mar 18.
3
PD1 Blockade Enhances ICAM1-Directed CAR T Therapeutic Efficacy in Advanced Thyroid Cancer.
Clin Cancer Res. 2020 Nov 15;26(22):6003-6016. doi: 10.1158/1078-0432.CCR-20-1523. Epub 2020 Sep 4.
4
Long noncoding RNA UCA1 promotes anaplastic thyroid cancer cell proliferation via miR‑135a‑mediated c‑myc activation.
Mol Med Rep. 2018 Sep;18(3):3068-3076. doi: 10.3892/mmr.2018.9276. Epub 2018 Jul 16.
5
miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.
Oncol Rep. 2016 Dec;36(6):3387-3396. doi: 10.3892/or.2016.5203. Epub 2016 Oct 25.
6
LncRNA suppresses CD8 T cells to confer resistance to cetuximab in colorectal cancer via miR-20b-5p/PD-L1 axis.
Epigenomics. 2021 Aug;13(16):1281-1297. doi: 10.2217/epi-2021-0130. Epub 2021 Sep 15.
7
Immune Profiling of Advanced Thyroid Cancers Using Fluorescent Multiplex Immunohistochemistry.
Thyroid. 2021 Jan;31(1):61-67. doi: 10.1089/thy.2020.0312. Epub 2020 Jul 28.
9
FOXP4-AS1 promotes CD8 T cell exhaustion and esophageal cancer immune escape through USP10-stabilized PD-L1.
Immunol Res. 2024 Aug;72(4):766-775. doi: 10.1007/s12026-024-09482-9. Epub 2024 Apr 30.
10
Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
Cancer Biol Ther. 2019;20(11):1355-1365. doi: 10.1080/15384047.2019.1617567. Epub 2019 Sep 10.

引用本文的文献

1
Long non-coding rnas as key modulators of the immune microenvironment in hepatocellular carcinoma: implications for Immunotherapy.
Front Immunol. 2025 Apr 25;16:1523190. doi: 10.3389/fimmu.2025.1523190. eCollection 2025.
3
The Application of microRNAs in Papillary Thyroid Cancer: A Bibliometric and Visualized Analysis.
Int J Gen Med. 2024 Oct 15;17:4681-4699. doi: 10.2147/IJGM.S487239. eCollection 2024.
5
Research progress of immunotherapy against anaplastic thyroid cancer.
Front Oncol. 2024 Mar 26;14:1365055. doi: 10.3389/fonc.2024.1365055. eCollection 2024.
6
Pinpointing Functionally Relevant miRNAs in Classical Hodgkin Lymphoma Pathogenesis.
Cancers (Basel). 2024 Mar 12;16(6):1126. doi: 10.3390/cancers16061126.
7
Long non-coding RNAs in cancer: multifaceted roles and potential targets for immunotherapy.
Mol Cell Biochem. 2024 Dec;479(12):3229-3254. doi: 10.1007/s11010-024-04933-1. Epub 2024 Feb 28.
8
Crosstalk between Thyroid Carcinoma and Tumor-Correlated Immune Cells in the Tumor Microenvironment.
Cancers (Basel). 2023 May 22;15(10):2863. doi: 10.3390/cancers15102863.
9
Noncoding RNAs Controlling Oxidative Stress in Cancer.
Cancers (Basel). 2023 Feb 10;15(4):1155. doi: 10.3390/cancers15041155.

本文引用的文献

1
long noncoding RNA induces autophagy to inhibit tumorigenesis of uveal melanoma by regulating key autophagy gene expression.
Autophagy. 2020 Jul;16(7):1186-1199. doi: 10.1080/15548627.2019.1659614. Epub 2019 Sep 3.
3
LncRNA-MTA2TR functions as a promoter in pancreatic cancer via driving deacetylation-dependent accumulation of HIF-1α.
Theranostics. 2019 Jul 9;9(18):5298-5314. doi: 10.7150/thno.34559. eCollection 2019.
4
Long Non-coding RNA FENDRR Acts as a miR-423-5p Sponge to Suppress the Treg-Mediated Immune Escape of Hepatocellular Carcinoma Cells.
Mol Ther Nucleic Acids. 2019 Sep 6;17:516-529. doi: 10.1016/j.omtn.2019.05.027. Epub 2019 Jun 12.
7
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression.
Nat Immunol. 2019 Jul;20(7):835-851. doi: 10.1038/s41590-019-0400-7. Epub 2019 Jun 3.
8
Targeting Super-Enhancer-Driven Oncogenic Transcription by CDK7 Inhibition in Anaplastic Thyroid Carcinoma.
Thyroid. 2019 Jun;29(6):809-823. doi: 10.1089/thy.2018.0550. Epub 2019 May 3.
9
MiR-873/PD-L1 axis regulates the stemness of breast cancer cells.
EBioMedicine. 2019 Mar;41:395-407. doi: 10.1016/j.ebiom.2019.02.034. Epub 2019 Feb 23.
10
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer.
Endocrine. 2019 Apr;64(1):122-129. doi: 10.1007/s12020-019-01865-5. Epub 2019 Feb 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验